Axon Enterprise, Inc. (NASDAQ:AXON) Shares Purchased by SteelPeak Wealth LLC

SteelPeak Wealth LLC boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 125.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,453 shares of the biotechnology company’s stock after acquiring an additional 809 shares during the period. SteelPeak Wealth LLC’s holdings in Axon Enterprise were worth $864,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of AXON. Public Sector Pension Investment Board boosted its position in shares of Axon Enterprise by 79.5% in the 2nd quarter. Public Sector Pension Investment Board now owns 2,604 shares of the biotechnology company’s stock valued at $766,000 after purchasing an additional 1,153 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in shares of Axon Enterprise by 1.2% in the second quarter. The Manufacturers Life Insurance Company now owns 43,367 shares of the biotechnology company’s stock valued at $12,760,000 after acquiring an additional 535 shares during the period. Creative Planning boosted its holdings in shares of Axon Enterprise by 9.6% in the second quarter. Creative Planning now owns 16,463 shares of the biotechnology company’s stock valued at $4,844,000 after acquiring an additional 1,441 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in shares of Axon Enterprise by 30.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 802 shares of the biotechnology company’s stock worth $236,000 after acquiring an additional 188 shares during the last quarter. Finally, EP Wealth Advisors LLC increased its holdings in shares of Axon Enterprise by 18.3% in the 2nd quarter. EP Wealth Advisors LLC now owns 1,577 shares of the biotechnology company’s stock valued at $464,000 after acquiring an additional 244 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Up 0.4 %

AXON stock opened at $639.97 on Thursday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company’s 50-day moving average price is $618.90 and its 200 day moving average price is $477.78. Axon Enterprise, Inc. has a 52 week low of $247.04 and a 52 week high of $698.67. The company has a market cap of $48.80 billion, a P/E ratio of 165.37, a P/E/G ratio of 6.09 and a beta of 1.04.

Insider Activity

In related news, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the transaction, the director now directly owns 24,259 shares of the company’s stock, valued at $15,518,239.71. This trade represents a 3.96 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the sale, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 50,545 shares of company stock worth $30,721,337. Company insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

AXON has been the topic of several research reports. TD Cowen assumed coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. Robert W. Baird raised their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Needham & Company LLC upped their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. The Goldman Sachs Group lifted their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday. Finally, Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $524.85.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.